International Circuit
Biomerica hires former Medtronic, GE executive as CFO
Biomerica Inc. announced the retirement of Janet Moore, the company’s chief financial officer (CFO). After many years of dedicated service, Moore has decided to retire and pursue personal interests. Moore will remain an employee of the company during a transition period to ensure a smooth transition. Moore, who also serves as a member of the Board of Directors and Corporate Secretary, will continue to serve as a member of the Board and as Corporate Secretary until the company’s Annual Meeting on Dec. 10. At that time, Moore will also be leaving the board.
“It has been my pleasure and privilege to serve as Biomerica’s CFO. The company has many talented, dedicated employees and innovative products which, I believe, will ensure the company’s continued success,” said Moore.
Biomerica has appointed Steve Sloan as the company’s new CFO. Sloan’s background and experience includes 13 years at General Electric with roles in internal audit, corporate finance and manufacturing finance. Most recently, Sloan spent 10 years with medical device maker Medtronic plc. At Medtronic, Sloan worked in four divisions, most recently serving as a divisional finance director.
Biomerica further announced that the Board has elected Cathy Coste as a new independent member of the Board. Coste has also been elected by the board to chair its Audit Committee, and to be a member of the Nominating and Corporate Governance Committee. Coste is a senior partner at Deloitte and Touche LLP, and retired in September. She has spent 32 years in both corporate and professional services positions leading global finance, internal audit and operations teams. For the past six years, Coste has served as Deloitte’s Life Sciences Industry Executive Leader. Coste is known for her expertise in governance, audit, risk and controls, and compliance and has served over 50 companies in the life science, technology, and consumer industries.
“Biomerica has a bold vision of developing a diagnostic guided therapy with its InFoods product. I’m honored to assume the role of Audit Committee Chairman and look forward to an exciting new fiscal year and beyond for Biomerica,” said Coste. MPO